Internal Medicine · Brooklyn, NY
NPI
1891010286
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2116 Avenue U
Brooklyn, NY, 11229
Phone (718) 616-1535
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
1,017 services
Medicare patients, 2024
166
Average age 73
Drug cost, 2024
$4.6M
25,323 prescriptions
Company payments, 2025
$1,241
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by York Sing Chan was code 99213 (office e&m - established), 482 times for 152 patients. In total York Sing Chan billed 1,017 services in 22 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 482 | 152 | $68.12 | $33K |
| 36415 Venipuncture Blood Collection | Office | 214 | 124 | $8.57 | $1,834 |
| G0008 Administration of influenza virus vaccine | Office | 62 | 60 | $37.09 | $2,300 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 62 | 62 | $147.47 | $9,143 |
| 90661 Vaccine Product | Office | 52 | 52 | $36.11 | $1,878 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 27 | 18 | $27.00 | $729 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 21 | 14 | $0.65 | $13.75 |
| 96372 Injection Administration | Office | 17 | 13 | $10.72 | $182 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 15 | 15 | $186.83 | $2,802 |
By year: 2022 $69K for 1,200 services; 2023 $60K for 1,033 services; 2024 $56K for 1,017 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 214 | 124 | $8.57 | $1,834 |
Medicare prescription drug claims, 2024
In 2024, the drug York Sing Chan prescribed most often to Medicare patients was Diclofenac Epolamine, with 1,245 prescriptions and refills. In total York Sing Chan wrote 25,323 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Epolamine Generic | 1,245 | 1,793 | 209 | $1.2M |
| Amlodipine Besylate Generic | 1,082 | 2,424 | 246 | $6,316 |
| Atorvastatin Calcium Generic | 944 | 2,034 | 215 | $6,947 |
| Vascepa Icosapent Ethyl | 836 | 1,440 | 169 | $500K |
| Diclofenac Sodium Generic | 803 | 891 | 196 | $180K |
| Simvastatin Generic | 682 | 1,505 | 143 | $4,812 |
| Metoprolol Succinate Generic | 669 | 1,482 | 156 | $6,941 |
| Losartan Potassium Generic | 664 | 1,473 | 152 | $5,108 |
| Metformin Hcl Generic | 542 | 1,051 | 106 | $2,808 |
| Fluticasone Propionate Generic | 520 | 540 | 119 | $5,579 |
| Ammonium Lactate Generic | 472 | 564 | 133 | $15K |
| Azelastine Hcl Generic | 435 | 490 | 111 | $8,903 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 427 | 436 | 88 | $11K |
| Tamsulosin Hcl Generic | 427 | 943 | 99 | $3,816 |
| Montelukast Sodium Generic | 387 | 801 | 130 | $2,896 |
Brand drugs: 4,941 claims; generic drugs: 19,804 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid York Sing Chan $1,241 ($1,241 in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $376.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 16 | $376 |
| Gilead Sciences, Inc. GILD | 8 | $200 |
| Amgen Inc. AMGN | 8 | $151 |
| Kowa Pharmaceuticals America, Inc. | 4 | $86.17 |
| Pfizer Inc. PFE | 4 | $85.63 |
| GlaxoSmithKline, LLC. GSK | 3 | $77.26 |
| Novo Nordisk Inc NVO | 3 | $68.87 |
| Genzyme Corporation SNY | 2 | $49.59 |
| Lilly USA, LLC LLY | 3 | $45.24 |
| Abbvie Inc. ABBV | 2 | $41.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.